Glaxosmithkline Pharmaceuticals standalone net profit rises 31.84% in the September 2017 quarter
Sales rise 4.65% to Rs 836.26 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 31.84% to Rs 130.32 crore in the quarter ended September 2017 as against Rs 98.85 crore during the previous quarter ended September 2016. Sales rose 4.65% to Rs 836.26 crore in the quarter ended September 2017 as against Rs 799.12 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales836.26799.12 5 OPM %22.9717.61 -PBDT201.70158.82 27 PBT193.97152.24 27 NP130.3298.85 32Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 25 2017 | 4:59 PM IST